Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Moderna and Pfizer's shots were revised this year to target the KP.2 variant of SARS-CoV-2, the virus that causes COVID-19, as part of a now-annual process undertaken by the FDA and health ...

FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups MONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 ...

Oklahomans should not have to fight their health insurer for the right to breathe. Blue Cross Blue Shield must abandon this new policy.

TULSA, Okla. — The memorial procession held in honor of a fallen Disney firefighter passed through Tulsa. 31-year-old Billy ...

The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to ...

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

The roughly 80-person company has raised more than $200 million over eight years. On the edge of FDA clearance for its sepsis test, a South Bay company raised $57 million to help with the test's ...

Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml).

Regeneron on Wednesday said the FDA green light covers Lynozyfic in adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a ...

Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment Provided by Dow Jones Jul 2, 2025, 3:39:00 PM. By Colin Kellaher .